Amneal Pharmaceuticals, Inc. - Class A Common Stock — Cash Flow (NASDAQ:AMRX)

Financials

Cash from operating activities 379 M241.82 M65.1 M345.58 M295.1 M339.99 M 305.84 M Cash from investing activities -317.55 M-194.18 M-174.31 M-69.19 M-63 M-112.26 M -116.17 M Cash from financing activities 131.81 M-138.12 M-106.62 M-212.57 M-211.79 M-31.53 M -51.42 M Free cash flow 379 M241.82 M65.1 M345.58 M295.1 M254.41 M 221.6 M

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

AMRX

Financials

Amneal Pharmaceuticals, Inc. - Class A Common Stock

News

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term

3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)

Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?

Teva’s CNS Portfolio Is Growing, But Valuation Is Stretched (NYSE:TEVA)

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

Do Options Traders Know Something About Amneal Stock We Don't?

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High?

Amneal Pharmaceuticals (AMRX) is a Top-Ranked Momentum Stock: Should You Buy?

Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?

Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?